Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity
1996

Evaluating Anti-Cancer Activity of Block Copolymer Micelles

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): EV Batrakova, TY Dorodnych, EY Klinskii, EN Kliushnenkov, OB Shemchukov, ON Goncharov, SA Arjakov, VY Alakhov, AV Kabanov

Primary Institution: Moscow Institute of Biotechnology, Inc.

Hypothesis

Can block copolymer micelles enhance the anti-cancer activity of anthracycline antibiotics in multidrug-resistant cancer cells?

Conclusion

The study found that drug/copolymer compositions significantly increased the lifespan of treated mice and inhibited tumor growth compared to free drugs.

Supporting Evidence

  • Drug/copolymer compositions showed a significant increase in lifespan (TIC> 150%) and tumor growth inhibition (>90%) in treated mice.
  • 33-50% of animals treated with effective doses showed complete disappearance of tumors.
  • The anti-tumor activity was dependent on the concentration of the copolymer and its hydrophobicity.

Takeaway

Researchers tested a new way to deliver cancer drugs using special micelles, which helped the drugs work better and made mice live longer.

Methodology

The study involved administering drug/copolymer compositions to mice with different types of cancer and measuring tumor growth and survival rates.

Limitations

The study primarily focused on murine models, which may not fully represent human responses.

Participant Demographics

Mice, specifically C57B1/6 male and BALB/c female mice, were used in the experiments.

Statistical Information

P-Value

p<0.002

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication